Skip to main contentAI and Advanced
/
ARVEE · NSEBSE SENSEX74,294.96-0.03%BSE |
NIFTY 5023,346.4+0.33%NSE |
NIFTY BANK56,358.7+0.54%NSE |
NIFTY IT28,854.55-1.03%NSE |
NIFTY AUTO27,129-0.11%NSE |
NIFTY FMCG45,466.8-0.23%NSE |
NIFTY PHARMA26,710.1+0.49%NSE |
NIFTY 50022,840.55+0.82%NSE |
AR
NSE · Equity shares · Chemical Manufacturing1.34 · 0.78%
Arvee Laboratories (India) ARVEE
NSE:INR 173.42
BSE:Not available
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for ARVEE
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 172.08
Day rangeINR 166.2 — INR 179
52-week rangeINR 129.11 — INR 290.78
Volume2,978
Market cap173
P/E58.45
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)31.51
Net Income (INR Cr)2.53
Rev Growth (5 Year %)-7.83
EPS Growth (5 Year %)-1.18
P/E Ratio58.45
Book Value30.66
EPS2.29
Price/BV5.66Computed
Research path: Interpret Arvee Laboratories (India)'s snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
ARVEEArvee Laboratories (India)1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 43.26 | 37.57 | 38.56 |
| Other Liabilities Total | 0.31 | 0.47 | 0.48 |
| Long Term Debt | 1.11 | 1.03 | 1 |
| Common Stock Total | 11.02 | 11.02 | 11.02 |
| Other Current Assets Total | 2.31 | 1.77 | 2.58 |
| Total Assets | 43.26 | 37.57 | 38.56 |
| Cash | 0.44 | 0.21 | 1.85 |
| Total Equity | 33.79 | 31.26 | 29.11 |
| Long Term Investments | 0.25 | 1.07 | 5.67 |
| Retained Earnings(Accumulated Deficit) | 22.77 | 20.24 | 18.09 |
| Total Common Shares Outstanding | 1.1 | 1.1 | 1.1 |
| Tangible Book Valueper Share Common Eq | 30.66 | 28.37 | 26.42 |
| Total Liabilities | 9.47 | 6.31 | 9.45 |
| Total Debt | 1.11 | 1.03 | 1 |
| Short Term Investments | 2.84 | 4.7 | 0.02 |
| Cashand Short Term Investments | 3.28 | 4.91 | 1.87 |
| Total Receivables Net | 10.45 | 8.43 | 6.13 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Deferred Income Tax | 0.51 | 0.98 | 0.84 |
| Accounts Receivable-Trade Net | 10.45 | 8.41 | 6.12 |
| Property/Plant/Equipment Total-Net | 17.61 | 16 | 15.29 |
| Total Current Liabilities | 7.54 | 3.83 | 7.13 |
| Total Inventory | 9.19 | 4.55 | 6.4 |
| Accounts Payable | 6.37 | 3.27 | 6.62 |
| Other Currentliabilities Total | 1.17 | 0.55 | 0.5 |
| Total Long Term Debt | 1.11 | 1.03 | 1 |
| Intangibles Net | 0 | 0 | 0 |
| Other Long Term Assets Total | 0.16 | 0.66 | 0.43 |
| Total Current Assets | 25.23 | 19.66 | 16.98 |
| Accumulated Depreciation Total | Not available | -20.61 | -19.47 |
| Current Portof LT Debt/Capital Leases | Not available | 0 | 0 |
| Property/Plant/Equipment Total-Gross | Not available | 35.88 | 32.13 |
| Note Receivable-Long Term | Not available | 0.18 | 0.18 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %-33.98
Margins
Operating Margin 12m6.3
Operating Margin 5y Avg7.17
Net Profit Margin 12m8.02
Net Profit Margin 5y6.15
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio5.49
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,674.1 | 2.56 L | 58.14 | — |
| Pidilite Industries | INR 1,576.4 | 1.60 L | 64.75 | — |
| Solar Industries India | INR 18,901.15 | 1.71 L | 102.64 | — |
| SRF | INR 2,868.9 | 85,283.53 | 44.53 | — |
| Linde India | INR 6,897.45 | 58,824.36 | 108.69 | — |
Shareholding
Ownership
- Promoter
- 73.50%
- Other
- 26.50%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Enterprise value to revenue forward of Arvee Laboratories (India) Ltd. – NSE:ARVEE - TradingViewMarket news · 28 Jun 2026, 4:25 am
Enterprise value to revenue forward of Arvee Laboratories (India) Ltd. – NSE:ARVEE TradingView
Arvee Laboratories Closes Trading Window Ahead of June Quarter Results - TipRanksMarket news · 27 Jun 2026, 8:54 pm
Arvee Laboratories Closes Trading Window Ahead of June Quarter Results TipRanks
Arvee Laboratories promoters report no share encumbrances in FY26 - scanx.tradeMarket news · 16 Jun 2026, 6:30 am
Arvee Laboratories promoters report no share encumbrances in FY26 scanx.trade
Arvee Laboratories (India) Ltd is Rated Strong Sell - Markets MojoMarket news · 1 Jun 2026, 2:18 pm
Arvee Laboratories (India) Ltd is Rated Strong Sell Markets Mojo
Arvee Laboratories (India) Ltd is Rated Strong Sell - Markets MojoMarket news · 20 May 2026, 4:38 pm
Arvee Laboratories (India) Ltd is Rated Strong Sell Markets Mojo
Arvee Lab Standalone March 2026 Net Sales at Rs 10.80 crore, up 67.51% Y-o-Y - Moneycontrol.comMarket news · 20 May 2026, 12:30 pm
Arvee Lab Standalone March 2026 Net Sales at Rs 10.80 crore, up 67.51% Y-o-Y Moneycontrol.com
Corporate actions
Events
- board MeetingsTo consider Other business matters. (Revised)
- board MeetingsTo consider Other business matters.
- board MeetingsTo consider Other business matters.
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
- board MeetingsTo consider Other business matters.
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Arvee Laboratories (India)
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Arvee Laboratories (India) Limited is an India-based company. The Company is engaged in manufacturing of specialized chemicals. It operates through Textile and Non-Textile segments. It offers polymer modifiers, contrast media intermediates, and drug intermediates. Its polumer modifier products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt, and 5-Sodiosulfo-Bis-Isophthalate. Its contrast media intermediate products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, 3,5-Dinitrobenzoic Acid, and 3,5-Diamino Benzoic Acid. Its drug intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine, and 2-Chloro-5-Nitrobenzoic Acid.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- ARVEE
Questions
Stock FAQ
What is the symbol and ISIN of Arvee Laboratories (India)?
Arvee Laboratories (India) has the symbol ARVEE and ISIN - INE006Z01016.
What is the current price of Arvee Laboratories (India)?
Arvee Laboratories (India) is currently trading at INR 173.42.
What are the year high and year low of Arvee Laboratories (India)?
Arvee Laboratories (India) has a year high of INR 290.78 and a year low of INR 129.11.
What is the market capitalization of Arvee Laboratories (India)?
Arvee Laboratories (India) has a market capitalization of INR 173.00 crore.
What is the P/E ratio of Arvee Laboratories (India)?
Arvee Laboratories (India) has a P/E ratio of 58.45.
What is the dividend yield of Arvee Laboratories (India)?
Arvee Laboratories (India) has a dividend yield of 0.00%.
How is the financial performance of Arvee Laboratories (India) based on revenue, net income, and EPS?
Arvee Laboratories (India) has revenue of INR 31.51 crore, net income of INR 2.53 crore, and EPS of INR 2.29.
What is the book value of Arvee Laboratories (India)?
Arvee Laboratories (India) has a book value of INR 30.66.
What is the debt-to-equity ratio of Arvee Laboratories (India)?
Arvee Laboratories (India) has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Arvee Laboratories (India)?
Arvee Laboratories (India) has a price-to-book ratio of 5.66 and a price-to-sales ratio of 5.49.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.